PatientView | USA innsikt fra pasientgrupper: En plass ved prisbordet

Pasientgruppers mål

Prosentandelene nedenfor fremhever hvordan de 91 pasientgruppene samhandler med regulatorer og taler for pasientinteresser. Siden respondenter kan være representert i mer enn ett område, er det ikke sikkert at prosentandelene summerer til 100 %.

interaksjoner

Hvordan pasientgrupper samhandler med legemiddelregulatorer

Finn ut hva målene betyr

32 omtaler

17 omtaler

15 omtaler

11 omtaler

5 omtaler

1 nevn

handlinger & påvirkning

Hvordan pasientgrupper får tilgang til legemidler

Finn ut hva målene betyr

27 omtaler

22 omtaler

3 omtaler

2 omtaler

Engelsk tekst	Terapiområde	Kategori	Pasienter nådd	Geografisk rekkevidde	Regulatorisk engasjement	Respondent
Our community members participate in this at an individual level, and as an organisation, we meet with industry policy holders.	Kreft > Kreft: kvinner	Regulatorisk partnerskap > Samarbeid med regulatoriske myndigheter	10 000	International	Rarely	119028011659
We collaborated on an externally-led Patient-Focused Drug Development meeting with the FDA [Food and Drug Administration] in 2025.	Nevrologisk > Multippel sklerose	Regulatorisk partnerskap > Samarbeid med regulatoriske myndigheter	100 000	National	Rarely	119039458452
We engage in education, guidance, and institutional dialogue initiatives to promote informed, equitable decisions that place community well-being at their centre.	Pasientadvokasi > Opplæring	Regulatorisk partnerskap > Samarbeid med regulatoriske myndigheter	100 000	International	Regularly	119063146174
Through written comments, sign-on letters, and participating in roundtable meetings where drugs are being discussed.	Kreft > Kreft: sarkom	Regulatorisk partnerskap > Samarbeid med regulatoriske myndigheter	10 000	International	Sometimes	119064713792
Just recently hosted an EL-PFDD [Externally-Led Patient-Focused Drug Development] meeting and attended FDA [Food and Drug Administration] meetings with industry partners.	Sjelden > Sjeldne lidelser: genetisk	Regulatorisk partnerskap > Samarbeid med regulatoriske myndigheter	5 000	International	Regularly	119065526277
... We work closely with the FDA and other drug agencies, like EMA [European Medicines Agency] and PDMA [Pharmaceuticals and Medical Devices Agency], to look at endpoints for drug trials, or how to improve drug trials to benefit sponsors and patients.	Nyre > Nyresykdommer	Regulatorisk partnerskap > Samarbeid med regulatoriske myndigheter	100 000	National	Regularly	119070696943
Participation in activities like PDUFA [Prescription Drug User Fee Act] and MDUFA [Medical Device User Fee and Modernization Act] discussions.	Sjelden > Sjeldne sykdommer: de fleste typer	Regulatorisk partnerskap > Samarbeid med regulatoriske myndigheter	100 000	National	Rarely	119078556821
We have a policy committee and weigh in on public policy issues through education and advocacy.	Kronisk > Palliativ	Regulatorisk partnerskap > Samarbeid med regulatoriske myndigheter	100	National	Regularly	119078649119
Discussions about review and approvals of new screening technologies.	Kreft > Kreft: de fleste typer	Regulatorisk partnerskap > Delta i vurderinger av medisinsk teknologi (HTA) og refusjonsgjennomganger	100 000	National	Rarely	119045117950
Our organisation actively advocates for the interests of the individuals and communities we serve before regulatory authorities and decision-making bodies on matters relating to medicine access, affordability, and coverage recommendations.	Pasientadvokasi > Opplæring	Regulatorisk partnerskap > Delta i vurderinger av medisinsk teknologi (HTA) og refusjonsgjennomganger	100 000	International	Regularly	119063146174
... Our government relations team responds to comment letters and regularly talks with CMS [Centers for Medicare & Medicaid Services] to ensure best outcomes.	Nyre > Nyresykdommer	Regulatorisk partnerskap > Delta i vurderinger av medisinsk teknologi (HTA) og refusjonsgjennomganger	100 000	National	Regularly	119070696943
Our organization has participated in responses to ICER [Institute for Clinical and Economic Review].	Respiratorisk > Lungesykdommer	Regulatorisk partnerskap > Delta i vurderinger av medisinsk teknologi (HTA) og refusjonsgjennomganger	100 000	International	Rarely	119078556838
We are typically advisors on ICER [Institute for Clinical and Economic Review] reviews.	Reumatisk > Lupus	Regulatorisk partnerskap > Delta i vurderinger av medisinsk teknologi (HTA) og refusjonsgjennomganger	100 000	National	Regularly	119082751826
Testifying on behalf of pharma & device companies in front of the FDA [Food and Drug Administration].	Transplantasjoner > Transplantasjoner: hjerte og lunge	Regulatorisk partnerskap > Delta/fasilitere møter med beslutningstakere/regulatorer	5 000	Local	Regularly	119014633092
Discussions with FDA [Food and Drug Administration].	Generell helse > Mangfoldige samfunn	Regulatorisk partnerskap > Delta/fasilitere møter med beslutningstakere/regulatorer	10 000	International	Rarely	119026771169
I personally have testified before the FDA [Food and Drug Administration] and CMS [Centers for Medicare & Medicaid Services].	Transplantasjoner > Transplantasjoner: hjerte og lunge	Regulatorisk partnerskap > Delta/fasilitere møter med beslutningstakere/regulatorer	1 000	Regional	Sometimes	119037216727
We collaborated on an externally-led Patient-Focused Drug Development meeting with the FDA [Food and Drug Administration] in 2025.	Nevrologisk > Multippel sklerose	Regulatorisk partnerskap > Delta/fasilitere møter med beslutningstakere/regulatorer	100 000	National	Rarely	119039458452
Meeting with people at CMS [Centers for Medicare & Medicaid Services] to weigh in on drug pricing negotiation potential consequences.	Sjelden > Sjeldne sykdommer: de fleste typer	Regulatorisk partnerskap > Delta/fasilitere møter med beslutningstakere/regulatorer	5 000	National	Sometimes	119046591776
Elevating the patient voice and sharing insights from our patient experience registry at meetings such as ODAC [Oncologic Drugs Advisory Committee] and MDPNP [Medical Device Patient Network Program] listening sessions.	Kreft > Kreft: annet	Regulatorisk partnerskap > Delta/fasilitere møter med beslutningstakere/regulatorer	100 000	International	Regularly	119047535935
Communications with FDA [Food and Drug Administration], participating in public comment sessions.	Blod > Anemi	Regulatorisk partnerskap > Delta/fasilitere møter med beslutningstakere/regulatorer	5 000	National	Regularly	119050770645
We work with FDA [Food and Drug Administration], Congress, and the White House on federal policies that affect liver patients.	Lever > Leversykdommer: de fleste typer	Regulatorisk partnerskap > Delta/fasilitere møter med beslutningstakere/regulatorer	100 000	International	Regularly	119054948119
Testifying at ODAC [Oncologic Drugs Advisory Committee].	Kreft > Kreft: annet	Regulatorisk partnerskap > Delta/fasilitere møter med beslutningstakere/regulatorer	100 000	International	Sometimes	119059387919
Just recently hosted an EL-PFDD [Externally-Led Patient-Focused Drug Development] meeting and attended FDA [Food and Drug Administration] meetings with industry partners.	Sjelden > Sjeldne lidelser: genetisk	Regulatorisk partnerskap > Delta/fasilitere møter med beslutningstakere/regulatorer	5 000	International	Regularly	119065526277
EL-PFDD [Externally-Led Patient-Focused Drug Development] FDA [Food and Drug Administration] Patient Listening Sessions.	Pasientadvokasi > Helseaktivist	Regulatorisk partnerskap > Delta/fasilitere møter med beslutningstakere/regulatorer	10 000	National	Regularly	119066130575
We have testified at FDA [Food and Drug Administration] Adcomms [Advisory Committees] and have helped organise Patient-Focused Drug Development meetings.	Nevromuskulær > Nevromuskulære sykdommer: de fleste typer	Regulatorisk partnerskap > Delta/fasilitere møter med beslutningstakere/regulatorer	100 000	National	Sometimes	119068005400
Actively participate in Patient Focused Drug Development with FDA [Food and Drug Administration].	Reumatisk > Lupus	Regulatorisk partnerskap > Delta/fasilitere møter med beslutningstakere/regulatorer	100 000	National	Regularly	119070039917
We have held multiple externally led patient-focused drug development (EL-PFDD [Externally Led Patient-Focused Drug Development]) meetings with the FDA [Food and Drug Administration]. We invite regulators to all our scientific workshops. We educate patients and facilitate meetings with regulators on an ongoing basis.	Nyre > Nyresykdommer	Regulatorisk partnerskap > Delta/fasilitere møter med beslutningstakere/regulatorer	100 000	National	Regularly	119070696943
We provide public comment on new drugs to the FDA [Food and Drug Administration].	Blod > Sigdcelleanemi	Regulatorisk partnerskap > Delta/fasilitere møter med beslutningstakere/regulatorer	10 000	Regional	Sometimes	119074242460
Participation in activities like PDUFA [Prescription Drug User Fee Act] and MDUFA [Medical Device User Fee and Modernization Act] discussions.	Sjelden > Sjeldne sykdommer: de fleste typer	Regulatorisk partnerskap > Delta/fasilitere møter med beslutningstakere/regulatorer	100 000	National	Rarely	119078556821
Coalition work.	Sjelden > Sjeldne sykdommer: pasientrettigheter	Regulatorisk partnerskap > Med andre helseadvokater	100 000	National	Sometimes	119050874740
We lead the national coalition EACH [Ensuring Access through Collaborative Health]/PIC [Patient Inclusion Council] coalition, working on government drug affordability reviews.	Autoimmun > Autoimmun: annet	Regulatorisk partnerskap > Med andre helseadvokater	100 000	International	Regularly	119071535440
In Arizona and, on occasion, more broadly across the USA, we collaborate with other cancer groups, organisations, and legislators.	Kreft > Kreft: blod	Regulatorisk partnerskap > Med andre helseadvokater	Do not know	Regional	Sometimes	119078394447
Lobbying on the state and federal level on rules/laws that impact our patients.	Generell helse > Helsetjenester	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	100	National	Sometimes	119011450240
Our Cancer Policy Institute advocates for equitable access to medicines to government organizations such as CMS [Centers for Medicare & Medicaid Services].	Kreft > Kreft: annet	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	100 000	International	Regularly	119020437168
We include a discussion of medication pricing in our conversations with the state and federal government employees. We are also pushing for lifetime coverage of physical therapy for people with PD [Parkinson's Disease], as maintaining balance as the disease progresses saves both providers and insurers money in the long run.	Nevrodegenerativ > Parkinsons	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	100 000	Regional	Rarely	119020536956
Advocacy with PBM [Pharmacy Benefit Manager], Medicare and state legislatures.	Reumatisk > Lupus	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	5 000	Regional	Sometimes	119037794627
Advocacy with PBM [Pharmacy Benefit Manager], Medicare and state legislatures.	Reumatisk > Lupus	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	5 000	Regional	Sometimes	119037794627
...The organization's flagship event - the annual Indo US Bridging RARE Summit brings together rare disease stakeholders, including scientists, patient advocates, government officials, biopharma executives, and policy experts who share a common goal: transforming the future of care for the 400 million people worldwide living with rare diseases.	Sjelden > Sjeldne sykdommer: de fleste typer	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	100	International	Regularly	119038170136
Invitation to the White House in 2024 to discuss cancer research funding with the First Lady's office.	Kreft > Kreft: medisinsk forskning	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	1 000	National	Rarely	119044810653
We work with FDA [Food and Drug Administration], Congress, and the White House on federal policies that affect liver patients.	Lever > Leversykdommer: de fleste typer	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	100 000	International	Regularly	119054948119
We frequently engage on state and federal issues related to patient access to care.	Respiratorisk > Lungesykdommer	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	100 000	National	Rarely	119055217525
We regularly advocate through sign-on letters, policymaker discussions, and policy related programming.	Kreft > Kreft: ulike samfunn	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	5 000	National	Sometimes	119055664199
We both authored and signed on to letters to state and federal (private insurance and CMS [Centers for Medicare & Medicaid Services]) on a variety of issues.	Kardiovaskulær > Kardiovaskulære & hjertetilstander	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	Over 100,000	International	Sometimes	119058234393
Campaigning with KidneyCAN for increased federal research funding.	Kreft > Kreft: nyre	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	1 000	Regional	Sometimes	119059282158
The Community Liver Alliance represents patient interests to regulators and policymakers responsible for advising on and determining drug pricing. We engage at the federal and state levels to ensure that the lived experiences of people affected by liver disease inform policy decisions related to drug access, affordability, and reimbursement. Our advocacy includes engagement with CMS [Centers for Medicare & Medicaid Services], participation in public comment opportunities (including those related to Medicare Drug Price Negotiation), collaboration with policymakers on PBM [Pharmacy Benefit Manager] reform, and education of regulatory stakeholders about the real-world impact of pricing decisions on patients with chronic and rare liver diseases. We elevate patient and caregiver voices to ensure pricing policies balance innovation with equitable and timely access to life-saving therapies.	Lever > Leversykdommer: de fleste typer	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	100 000	National	Regularly	119059491202
We communicate with federal representatives about the importance of funding.	Kreft > Kreft: hjerne	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	We do not communicate with patients directly	National	Sometimes	119061001133
We bring patient perspectives opposing use of QALYs [Quality-Adjusted Life Years].	Pasientadvokasi > Helseaktivist	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	Do not know	National	Regularly	119065430409
Just one example: we continually advocate (both through regulatory comments and now legislation) for adequate reimbursement for new and innovative drugs in the ESRD [End-Stage Renal Disease] space through TDAPA [Transitional Drug Add-on Payment Adjustment] and a sustainable post-TDAPA payment pathway.	Nyre > Nyresykdommer	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	Over 100,000	National	Regularly	119068073151
We work with state, federal policymakers and health insurers.	Generell helse > Fedme	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	Over 100,000	National	Sometimes	119068989651
As a transgender-led healthcare organization, ETSI [Ending Transmission of Sexual Infections] also brings the perspective of historically marginalized communities into healthcare discussions. The clinic advocates for policies that protect medication affordability, expand HIV prevention services, and strengthen programs that reduce the cost of prescription drugs for safety-net providers. Through patient care, community engagement, and participation in public health programs, ETSI Health Clinic ensures that the voices and needs of vulnerable patients are represented in conversations about medication access and healthcare equity.	HIV > HIV og seksuell helse	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	100	Regional	Regularly	119073874628
Supported efforts to have an ICD-10 (International Classification of Diseases, 10th Revision) code for VEXAS syndrome.	Sjelden > Autoinflammatiske sykdommer	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	1 000	International	Sometimes	119074154009
We provide public comment on new drugs to the FDA. We regularly organize delegations to Capitol Hill to advocate for Medicaid and Medicare support for sickle cell treatment. We advocate with New Jersey legislators for support for sickle cell treatment and services.	Blod > Sigdcelleanemi	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	10 000	Regional	Sometimes	119074242460
Testifying at PDAB meetings [submitting comments to a Patient Drug Affordability Board during a public meeting, hearing, or review process] writing letters to decision-makers at state and federal level [USA].	Sjelden > Cystisk fibrose	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	10 000	National	Sometimes	119078388026
In Arizona and occasionally, the U.S., we collaborate with other cancer groups, organizations, and legislators who support legislation that will help cancer research, the medical/oncology groups, and cancer patients and families.	Kreft > Kreft: blod	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	Do not know	Regional	Sometimes	119078394447
We have a policy committee and weigh in on public policy issues through education and advocacy.	Kronisk > Palliativ	Påvirkning av politikk og lovgivning > Påvirk helsepolitikk og lovgivning	100	National	Regularly	119078649119
We include a discussion of medication pricing in our discussions with state and federal government employees.	Nevrodegenerativ > Parkinsons	Påvirkning av politikk og lovgivning > Delta i offentlige høringer og konsultasjoner	100 000	Regional	Rarely	119020536956
We submitted comments to CMS [Centers for Medicare & Medicaid Services] regarding the price negotiation of mental health and neurological conditions.	Psykisk helse > Psykisk helse: stigma	Påvirkning av politikk og lovgivning > Delta i offentlige høringer og konsultasjoner	We do not communicate with patients directly	National	Sometimes	119024698241
IndoUSrare participates in RDLA's [Rare Disease Legislative Advocates] Rare Disease Week on Capitol Hill and advocates to legislators on behalf of our patient alliance members and the rare disease community.	Sjelden > Sjeldne sykdommer: de fleste typer	Påvirkning av politikk og lovgivning > Delta i offentlige høringer og konsultasjoner	100	International	Regularly	119038170136
Testify before prescription drug affordability boards.	Blødning > Blødningsforstyrrelser: de fleste typer	Påvirkning av politikk og lovgivning > Delta i offentlige høringer og konsultasjoner	1 000	Local	Regularly	119044404340
Communications with FDA [Food and Drug Administration], participating in public comment sessions.	Blod > Anemi	Påvirkning av politikk og lovgivning > Delta i offentlige høringer og konsultasjoner	5 000	National	Regularly	119050770645
We regularly advocate through sign-on letters, policymaker discussions, and policy related programming.	Kreft > Kreft: ulike samfunn	Påvirkning av politikk og lovgivning > Delta i offentlige høringer og konsultasjoner	5 000	National	Sometimes	119055664199
We both authored and signed on to letters to state and federal (private insurance and CMS [Centers for Medicare & Medicaid Services]) on a variety of issues.	Kardiovaskulær > Kardiovaskulære & hjertetilstander	Påvirkning av politikk og lovgivning > Delta i offentlige høringer og konsultasjoner	Over 100,000	International	Sometimes	119058234393
... Testifying at IRA [Inflation Reduction Act] listening sessions to elevate the patient experience.	Kreft > Kreft: annet	Påvirkning av politikk og lovgivning > Delta i offentlige høringer og konsultasjoner	100 000	International	Sometimes	119059387919
The Community Liver Alliance engages at the federal and state levels to ensure that the lived experiences of people affected by liver disease inform policy decisions related to drug access, affordability, and reimbursement. The Community Liver Alliance's advocacy includes engagement with CMS [Centers for Medicare & Medicaid Services], participation in public comment opportunities (including those related to Medicare Drug Price Negotiation), collaboration with policymakers on PBM [Pharmacy Benefit Manager] reform, and education of regulatory stakeholders about the real-world impact of pricing decisions on patients with chronic and rare liver diseases.	Lever > Leversykdommer: de fleste typer	Påvirkning av politikk og lovgivning > Delta i offentlige høringer og konsultasjoner	100 000	National	Regularly	119059491202
Through written comments, sign-on letters, and participating in roundtable meetings where drugs are being discussed.	Kreft > Kreft: sarkom	Påvirkning av politikk og lovgivning > Delta i offentlige høringer og konsultasjoner	10 000	International	Sometimes	119064713792
We work with the state agencies that oversee our Medicaid program, our exchange and private insurance. We hold quarterly meetings with them to discuss patient access issues. We also provide letters and testimony to the board that oversees health care costs in our state.	Blødning > Blødningsforstyrrelser: de fleste typer	Påvirkning av politikk og lovgivning > Delta i offentlige høringer og konsultasjoner	5 000	Regional	Regularly	119069774462
... Our government relations team responds to comment letters and regularly talks with CMS [Centers for Medicare & Medicaid Services] to ensure best outcomes.	Nyre > Nyresykdommer	Påvirkning av politikk og lovgivning > Delta i offentlige høringer og konsultasjoner	100 000	National	Regularly	119070696943
We provided comments to federal and state regulators around drug pricing in the 340B program [in the US, these reforms seek to overhaul the 1992 federal program that mandates pharmaceutical manufacturers provide steep drug discounts to safety-net hospitals and clinics] when asking for community input to proposed policy changes.	Pasientopplæring > Pasientinformasjon	Påvirkning av politikk og lovgivning > Delta i offentlige høringer og konsultasjoner	5 000	National	Sometimes	119073380443
We are not a lobbying organization, we are a 501 c-3 non-profit public charity. We sign on to letters with partner societies who are lobbying for better access to care. We host roundtables and advocacy awareness days with legislators where we raise awareness of current problems and offer solutions. One recent event was with the Governor of Virginia. We are planning a Spine Health Fair at the US Capitol in September.	Generell helse > Livsstil	Påvirkning av politikk og lovgivning > Delta i offentlige høringer og konsultasjoner	100 000	National	Sometimes	119074217249
We provide public comment on new drugs to the FDA [Food and Drug Administration].	Blod > Sigdcelleanemi	Påvirkning av politikk og lovgivning > Delta i offentlige høringer og konsultasjoner	10 000	Regional	Sometimes	119074242460
Work with NYSTAG [New York State Technical Advisory Group-generally refers to ad-hoc or specialised panels of industry experts, academics, and stakeholders assembled by NY state agencies to advise on specific policies, healthcare, or emerging technologies.].	Generell helse > Helsetjenester	Påvirkning av politikk og lovgivning > Delta i offentlige høringer og konsultasjoner	5 000	Regional	Sometimes	119078326039
Testifying at PDAB meetings [submitting comments to a Patient Drug Affordability Board during a public meeting, hearing, or review process] writing letters to decision-makers at state and federal level [USA].	Sjelden > Cystisk fibrose	Påvirkning av politikk og lovgivning > Delta i offentlige høringer og konsultasjoner	10 000	National	Sometimes	119078388026
IndoUSrare participates in RDLA's [Rare Disease Legislative Advocates] Rare Disease Week on Capitol Hill and advocates to legislators on behalf of our patient alliance members and the rare disease community.	Sjelden > Sjeldne sykdommer: de fleste typer	Påvirkning av politikk og lovgivning > Mobiliser parlamentarikere og politiske ledere	100	International	Regularly	119038170136
Invitation to the White House in 2024 to discuss cancer research funding with the First Lady's office.	Kreft > Kreft: medisinsk forskning	Påvirkning av politikk og lovgivning > Mobiliser parlamentarikere og politiske ledere	1 000	National	Rarely	119044810653
We communicate with federal representatives about the importance of funding.	Kreft > Kreft: hjerne	Påvirkning av politikk og lovgivning > Mobiliser parlamentarikere og politiske ledere	We do not communicate with patients directly	National	Sometimes	119061001133
We provide public comment on new drugs to the FDA. We regularly organize delegations to Capitol Hill to advocate for Medicaid and Medicare support for sickle cell treatment. We advocate with New Jersey legislators for support for sickle cell treatment and services.	Blod > Sigdcelleanemi	Påvirkning av politikk og lovgivning > Mobiliser parlamentarikere og politiske ledere	10 000	Regional	Sometimes	119074242460
... We are active in Lupus Caucus [Congressional Lupus Caucus, a bipartisan group of lawmakers focused on raising awareness about lupus and securing federal funding for research and education]	Reumatisk > Lupus	Påvirkning av politikk og lovgivning > Mobiliser parlamentarikere og politiske ledere	100 000	National	Regularly	119082751826
Government Relations/Advocacy team signs letters in support of lower drug prices.	Kreft > Kreft: prostata	Prising og tilgjengelighetsadvokatur > Gå inn for rettferdig medisinprising	100 000	National	Sometimes	119011723588
We include a discussion of medication pricing in our discussions with state and federal government employees.	Nevrodegenerativ > Parkinsons	Prising og tilgjengelighetsadvokatur > Gå inn for rettferdig medisinprising	100 000	Regional	Rarely	119020536956
Testify before prescription drug affordability boards.	Blødning > Blødningsforstyrrelser: de fleste typer	Prising og tilgjengelighetsadvokatur > Gå inn for rettferdig medisinprising	1 000	Local	Regularly	119044404340
Drug assistance programs and co-pay assistance foundation.	Kreft > Kreft: de fleste typer	Prising og tilgjengelighetsadvokatur > Gå inn for rettferdig medisinprising	5 000	International	Sometimes	119045428228
We frequently engage on state and federal issues related to patient access to care, occasionally weighing in on issues adjacent to drug pricing, though it is not our primary focus.	Respiratorisk > Lungesykdommer	Prising og tilgjengelighetsadvokatur > Gå inn for rettferdig medisinprising	100 000	National	Rarely	119055217525
The Community Liver Alliance represents patient interests to regulators and policymakers responsible for advising on and determining drug pricing. We engage at the federal and state levels to ensure that the lived experiences of people affected by liver disease inform policy decisions related to drug access, affordability, and reimbursement. Our advocacy includes engagement with CMS [Centers for Medicare & Medicaid Services], participation in public comment opportunities (including those related to Medicare Drug Price Negotiation), collaboration with policymakers on PBM [Pharmacy Benefit Manager] reform, and education of regulatory stakeholders about the real-world impact of pricing decisions on patients with chronic and rare liver diseases. We elevate patient and caregiver voices to ensure pricing policies balance innovation with equitable and timely access to life-saving therapies	Lever > Leversykdommer: de fleste typer	Prising og tilgjengelighetsadvokatur > Gå inn for rettferdig medisinprising	100 000	National	Regularly	119059491202
Promoting 340B reforms [in the US, these reforms seek to overhaul the 1992 federal program that mandates pharmaceutical manufacturers provide steep drug discounts to safety-net hospitals and clinics].	Pasientadvokasi > Helseaktivist	Prising og tilgjengelighetsadvokatur > Gå inn for rettferdig medisinprising	10 000	Regional	Regularly	119059636045
Have written support letters from the "patient voice" as part of our advocacy efforts related to drug pricing.	Kreft > Kreft: hjerne	Prising og tilgjengelighetsadvokatur > Gå inn for rettferdig medisinprising	1 000	National	Rarely	119061176158
Our organisation actively advocates for the interests of the individuals and communities we serve before regulatory authorities and decision-making bodies on matters relating to medicine access, affordability, and coverage recommendations.	Pasientadvokasi > Opplæring	Prising og tilgjengelighetsadvokatur > Gå inn for rettferdig medisinprising	100 000	International	Regularly	119063146174
We bring patient perspectives opposing use of QUALYs [quality-adjusted life years] and opposing importing drug prices from other countries [oustide of the USA], especially those that use QALYs.	Pasientadvokasi > Helseaktivist	Prising og tilgjengelighetsadvokatur > Gå inn for rettferdig medisinprising	Do not know	National	Regularly	119065430409
Just one example: we continually advocate (both through regulatory comments and now legislation) for adequate reimbursement for new and innovative drugs in the ESRD [End-Stage Renal Disease] space through TDAPA [Transitional Drug Add-on Payment Adjustment] and a sustainable post-TDAPA payment pathway.	Nyre > Nyresykdommer	Prising og tilgjengelighetsadvokatur > Gå inn for rettferdig medisinprising	Over 100,000	National	Regularly	119068073151
We work with the state agencies that oversee our Medicaid program, our exchange and private insurance. We hold quarterly meetings with them to discuss patient access issues. We also provide letters and testimony to the board that oversees health care costs in our state.	Blødning > Blødningsforstyrrelser: de fleste typer	Prising og tilgjengelighetsadvokatur > Gå inn for rettferdig medisinprising	5 000	Regional	Regularly	119069774462
ETSI [Ending Transmission of Sexual Infections] Health Clinic represents the interests of patients—particularly those impacted by HIV, LGBTQ+ individuals, and underserved communities—by advocating for affordable access to life-saving medications.	HIV > HIV og seksuell helse	Prising og tilgjengelighetsadvokatur > Gå inn for rettferdig medisinprising	100	Regional	Regularly	119073874628
Pharma pricing.	Generell helse > Fedme	Prising og tilgjengelighetsadvokatur > Gå inn for rettferdig medisinprising	100 000	National	Regularly	119076659022
With our new Public Policy department, this may come up as an opportunity to advocate for drug pricing.	Nevrodegenerativ > Parkinsons	Prising og tilgjengelighetsadvokatur > Gå inn for rettferdig medisinprising	100 000	National	Sometimes	119078318937
Cost for SCD [Sickle Cell Disease] treatments as they came to market during the last 7 years.	Blod > Sigdcelleanemi	Prising og tilgjengelighetsadvokatur > Gå inn for rettferdig medisinprising	5 000	National	Sometimes	119079213376
We have participated in the IRA [Inflation Reduction Act] price negotiation round tables.	Respiratorisk > Astma og allergi	Prising og tilgjengelighetsadvokatur > Delta i forhandlinger med prisrevisjonsnemnd	100 000	National	Regularly	119011501209
We have participated in the IRA [Inflation Reduction Act of 2022] price negotiation round tables [The IRA provides Medicare (the US federal health insurance program for people age 65 and older) powers to negotiate lower prescription costs].	Respiratorisk > Astma og allergi	Prising og tilgjengelighetsadvokatur > Delta i forhandlinger med prisrevisjonsnemnd	100 000	National	Regularly	119011501209
We submitted comments to CMS [Centers for Medicare & Medicaid Services] regarding the price negotiation of mental health and neurological conditions.	Psykisk helse > Psykisk helse: stigma	Prising og tilgjengelighetsadvokatur > Delta i forhandlinger med prisrevisjonsnemnd	We do not communicate with patients directly	National	Sometimes	119024698241
... meetings with state office of CMS [Centers for Medicare & Medicaid Services].	Blødning > Blødningsforstyrrelser: de fleste typer	Prising og tilgjengelighetsadvokatur > Delta i forhandlinger med prisrevisjonsnemnd	1 000	Local	Regularly	119044404340
Meeting with people at CMS [Centers for Medicare & Medicaid Services] to weigh in on drug pricing negotiation potential consequences.	Sjelden > Sjeldne sykdommer: de fleste typer	Prising og tilgjengelighetsadvokatur > Delta i forhandlinger med prisrevisjonsnemnd	5 000	National	Sometimes	119046591776
We educate advocates on outreach to Patient Drug Affordability Boards [Patient Drug Affordability Boards are state government boards that review prescription drug prices and, in some US states, can take actions to help make drugs more affordable.]	Kreft > Kreft: ulike samfunn	Prising og tilgjengelighetsadvokatur > Delta i forhandlinger med prisrevisjonsnemnd	100 000	National	Sometimes	119054172981
The Community Liver Alliance's advocacy includes engagement with CMS [Centers for Medicare & Medicaid Services], participation in public comment opportunities (including those related to Medicare Drug Price Negotiation), collaboration with policymakers on PBM [Pharmacy Benefit Manager] reform, and education of regulatory stakeholders about the real-world impact of pricing decisions on patients with chronic and rare liver diseases.	Lever > Leversykdommer: de fleste typer	Prising og tilgjengelighetsadvokatur > Delta i forhandlinger med prisrevisjonsnemnd	100 000	National	Regularly	119059491202
PDABs [Prescription Drug Affordability Boards]; IRA [Inflation Reduction Act]; Medicaid P&T [Pharmacy and Therapeutics] committees.	Pasientadvokasi > Helseaktivist	Prising og tilgjengelighetsadvokatur > Delta i forhandlinger med prisrevisjonsnemnd	We do not communicate with patients directly	National	Regularly	119064160791
We participated in the Medicare price negotiation roundtables and town hall last year.	Respiratorisk > Astma og allergi	Prising og tilgjengelighetsadvokatur > Delta i forhandlinger med prisrevisjonsnemnd	100 000	National	Regularly	119069847466
Actively participate in patient-focused drug development with the FDA [Food and Drug Administration] and CMS [Centers for Medicare & Medicaid Services]/HHS [U.S. Department of Health and Human Services] Prescription Access discussions.	Reumatisk > Lupus	Prising og tilgjengelighetsadvokatur > Delta i forhandlinger med prisrevisjonsnemnd	100 000	National	Regularly	119070039917
We lead the national coalition EACH [Ensuring Access through Collaborative Health]/PIC [Patient Inclusion Council] coalition, working on government drug affordability reviews.	Autoimmun > Autoimmun: annet	Prising og tilgjengelighetsadvokatur > Delta i forhandlinger med prisrevisjonsnemnd	100 000	International	Regularly	119071535440
We provided comments to federal and state regulators around drug pricing in the 340B program [in the US, these reforms seek to overhaul the 1992 federal program that mandates pharmaceutical manufacturers provide steep drug discounts to safety-net hospitals and clinics] when asking for community input to proposed policy changes.	Pasientopplæring > Pasientinformasjon	Prising og tilgjengelighetsadvokatur > Delta i forhandlinger med prisrevisjonsnemnd	5 000	National	Sometimes	119073380443
We communicate to them that many HD [Huntington's disease] families are low income as often the one making the money is the one with HD. So cost of meds can impact whether they can afford the meds.	Nevrodegenerativ > Huntingtons sykdom	Prising og tilgjengelighetsadvokatur > Adresser kostnadsbarrierer for lavinntekts- og sårbare grupper	100 000	National	Sometimes	119017688949
Health insurance companies and health insurance reps organize activities for low income communities.	Eldre mennesker > Eldre mennesker	Prising og tilgjengelighetsadvokatur > Adresser kostnadsbarrierer for lavinntekts- og sårbare grupper	Over 100,000	International	Sometimes	119035935608
ETSI [Ending Transmission of Sexual Infections] Health Clinic represents the interests of patients—particularly those impacted by HIV, LGBTQ+ individuals, and underserved communities—by advocating for affordable access to life-saving medications and healthcare services. Through its participation in programs such as the 340B Drug Pricing Program [in the US, these reforms seek to overhaul the 1992 federal program that mandates pharmaceutical manufacturers provide steep drug discounts to safety-net hospitals and clinics], ETSI works to ensure that low-income and uninsured patients have access to reduced-cost prescription medications, including HIV treatment and prevention medications like PrEP.	HIV > HIV og seksuell helse	Prising og tilgjengelighetsadvokatur > Adresser kostnadsbarrierer for lavinntekts- og sårbare grupper	100	Regional	Regularly	119073874628
We regularly provide comments to state P&T [Pharmacy and Therapeutics] committees regarding their formulary inclusions and exclusions.	Respiratorisk > Astma og allergi	Prising og tilgjengelighetsadvokatur > Arbeide for inkludering av produkt i refusjonslister/nasjonale formularer	100 000	National	Regularly	119011501209
PDABs [Prescription Drug Affordability Boards]; IRA [Inflation Reduction Act]; Medicaid P&T [Pharmacy and Therapeutics] committees.	Pasientadvokasi > Helseaktivist	Prising og tilgjengelighetsadvokatur > Arbeide for inkludering av produkt i refusjonslister/nasjonale formularer	We do not communicate with patients directly	National	Regularly	119064160791
Invitation to the White House in 2024 to discuss cancer research funding with First Lady's office. Lastly, I've co-written op-eds and on the local level recorded a video (ACS) targeting NYS lawmakers and the advocacy for increased equity and access to biomarker testing for patients.	Kreft > Kreft: medisinsk forskning	Prising og tilgjengelighetsadvokatur > Engasjere seg i bevissthetskampanjer	1 000	National	Rarely	119044810653
Advocacy in access to care issues.	Kreft > Kreft: de fleste typer	Forbedrer tilgangsveier > Legge til rette for rettferdig tilgang til medisiner/helsetjenester	10 000	Regional	Sometimes	119011457943
Our Cancer Policy Institute advocates for equitable access to medicines to government organizations such as CMS [Centers for Medicare & Medicaid Services].	Kreft > Kreft: annet	Forbedrer tilgangsveier > Legge til rette for rettferdig tilgang til medisiner/helsetjenester	100 000	International	Regularly	119020437168
We include a discussion of medication pricing in our conversations with the state and federal government employees. We are also pushing for lifetime coverage of physical therapy for people with PD [Parkinson's Disease], as maintaining balance as the disease progresses saves both providers and insurers money in the long run.	Nevrodegenerativ > Parkinsons	Forbedrer tilgangsveier > Legge til rette for rettferdig tilgang til medisiner/helsetjenester	100 000	Regional	Rarely	119020536956
... We sent letters to States to request that they change their step requirements for access to mental health treatments.	Psykisk helse > Psykisk helse: stigma	Forbedrer tilgangsveier > Legge til rette for rettferdig tilgang til medisiner/helsetjenester	We do not communicate with patients directly	National	Sometimes	119024698241
Invitation to the White House in 2024 to discuss cancer research funding with First Lady's office. Lastly, I've co-written op-eds and on the local level recorded a video (ACS) targeting NYS lawmakers and the advocacy for increased equity and access to biomarker testing for patients.	Kreft > Kreft: medisinsk forskning	Forbedrer tilgangsveier > Legge til rette for rettferdig tilgang til medisiner/helsetjenester	1 000	National	Rarely	119044810653
Drug assistance programs and co-pay assistance foundation.	Kreft > Kreft: de fleste typer	Forbedrer tilgangsveier > Legge til rette for rettferdig tilgang til medisiner/helsetjenester	5 000	International	Sometimes	119045428228
We frequently engage on state and federal issues related to patient access to care.	Respiratorisk > Lungesykdommer	Forbedrer tilgangsveier > Legge til rette for rettferdig tilgang til medisiner/helsetjenester	100 000	National	Rarely	119055217525
The Community Liver Alliance elevates patient and caregiver voices to ensure pricing policies balance innovation with equitable and timely access to life-saving therapies.	Lever > Leversykdommer: de fleste typer	Forbedrer tilgangsveier > Legge til rette for rettferdig tilgang til medisiner/helsetjenester	100 000	National	Regularly	119059491202
We might provide patient stories and testimonials when needed to ensure importance of continued access to a particular drug.	Nevrologisk > Migrene/andre hodepinelidelser	Forbedrer tilgangsveier > Legge til rette for rettferdig tilgang til medisiner/helsetjenester	100 000	National	Rarely	119060019780
Our organisation actively advocates for the interests of the individuals and communities we serve before regulatory authorities and decision-making bodies on matters relating to medicine access, affordability, and coverage recommendations.	Pasientadvokasi > Opplæring	Forbedrer tilgangsveier > Legge til rette for rettferdig tilgang til medisiner/helsetjenester	100 000	International	Regularly	119063146174
State level Medicaid.	Kreft > Kreft: de fleste typer	Forbedrer tilgangsveier > Legge til rette for rettferdig tilgang til medisiner/helsetjenester	1 000	National	Rarely	119068136322
We work with the state agencies that oversee our Medicaid program, our exchange and private insurance. We hold quarterly meetings with them to discuss patient access issues. We also provide letters and testimony to the board that oversees health care costs in our state.	Blødning > Blødningsforstyrrelser: de fleste typer	Forbedrer tilgangsveier > Legge til rette for rettferdig tilgang til medisiner/helsetjenester	5 000	Regional	Regularly	119069774462
We are currently addressing access to biologic medications.	Sjelden > Sjeldne sykdommer: immunsystem	Forbedrer tilgangsveier > Legge til rette for rettferdig tilgang til medisiner/helsetjenester	10 000	National	Sometimes	119069849386
Actively participate in patient-focused drug development with the FDA [Food and Drug Administration] and CMS [Centers for Medicare & Medicaid Services]/HHS [U.S. Department of Health and Human Services] Prescription Access discussions.	Reumatisk > Lupus	Forbedrer tilgangsveier > Legge til rette for rettferdig tilgang til medisiner/helsetjenester	100 000	National	Regularly	119070039917
We are not a lobbying organization, we are a 501 c-3 non-profit public charity. We sign on to letters with partner societies who are lobbying for better access to care. Support with formal cost-approval (reimbursement authorisation) applications and with newly introduced restrictions on treatment options.	Generell helse > Livsstil	Forbedrer tilgangsveier > Legge til rette for rettferdig tilgang til medisiner/helsetjenester	100 000	National	Sometimes	119074217249
Pharma pricing, coverage, indications.	Generell helse > Fedme	Forbedrer tilgangsveier > Legge til rette for rettferdig tilgang til medisiner/helsetjenester	100 000	National	Regularly	119076659022
We have on only a few occasions advocated for better access to newer drugs.	Psykisk helse > Psykisk helse: stigma	Forbedrer tilgangsveier > Legge til rette for rettferdig tilgang til medisiner/helsetjenester	Over 100,000	International	Rarely	119078209025
Cost for SCD [Sickle Cell Disease] treatments as they came to market during the last 7 years.	Blod > Sigdcelleanemi	Forbedrer tilgangsveier > Legge til rette for rettferdig tilgang til medisiner/helsetjenester	5 000	National	Sometimes	119079213376
... convene MAPRx [Medicare Access for Patients Rx] for Medicare Part D, etc.[MAPRx is guided by the idea that every Medicare Part D beneficiary should have timely, affordable access to the medications they need to live a healthy life.]	Reumatisk > Lupus	Forbedrer tilgangsveier > Legge til rette for rettferdig tilgang til medisiner/helsetjenester	100 000	National	Regularly	119082751826
... We sent letters to States to request that they change their step requirements for access to mental health treatments.	Psykisk helse > Psykisk helse: stigma	Forbedrer tilgangsveier > Adresser ulikheter i tilgang og administrasjon	We do not communicate with patients directly	National	Sometimes	119024698241
We work with the state agencies that oversee our Medicaid program, our exchange and private insurance. We hold quarterly meetings with them to discuss patient access issues. We also provide letters and testimony to the board that oversees health care costs in our state.	Blødning > Blødningsforstyrrelser: de fleste typer	Forbedrer tilgangsveier > Adresser ulikheter i tilgang og administrasjon	5 000	Regional	Regularly	119069774462
IndoUSrare participates in RDLA's [Rare Disease Legislative Advocates] Rare Disease Week on Capitol Hill and advocates to legislators on behalf of our patient alliance members and the rare disease community.	Sjelden > Sjeldne sykdommer: de fleste typer	Forbedrer tilgangsveier > Forbedring av tilgang til sjeldne/ultrasjelne terapier	100	International	Regularly	119038170136
Elevating the patient voice and sharing insights from our patient experience registry at meetings such as ODAC [Oncologic Drugs Advisory Committee] and MDPNP [Medical Device Patient Network Program] listening sessions.	Kreft > Kreft: annet	Evidensbasert pasientinnspill > Bruk pasientinnsikt til å informere beslutninger	100 000	International	Regularly	119047535935
Elevating the patient voice and sharing insights from our patient experience registry at meetings such as ODAC [Oncologic Drugs Advisory Committee] and MDPNP [Medical Device Patient Network Program] listening sessions.	Kreft > Kreft: annet	Evidensbasert pasientinnspill > Bruk pasientinnsikt til å informere beslutninger	100 000	International	Regularly	119047535935
Held an EL-PFDD [Externally-Led Patient-Focused Drug Development] meeting.	Nevrodegenerativ > Demens	Evidensbasert pasientinnspill > Bruk pasientinnsikt til å informere beslutninger	Do not know	National	Sometimes	119052219350
Serve on the Alliance for Breast Cancer Policy [The Alliance for Breast Cancer Policy is a coalition of over 25 national patient advocacy organizations founded by Susan G. Komen. The network unites advocates, community members, and industry partners to drive federal policy changes that improve access to care, eliminate out-of-pocket costs, and improve outcomes]. We were just part of a manuscript written for the launch of the global Breast Cancer Care Quality Index: https://www.mdpi.com/1660-4601/23/2/207	Kreft > Kreft: bryst	Evidensbasert pasientinnspill > Bruk pasientinnsikt til å informere beslutninger	100 000	International	Sometimes	119052475951
We bring patient perspectives opposing use of QALYs [Quality-Adjusted Life Years].	Pasientadvokasi > Helseaktivist	Evidensbasert pasientinnspill > Bruk pasientinnsikt til å informere beslutninger	Do not know	National	Regularly	119065430409
Actively participate in Patient Focused Drug Development with FDA [Food and Drug Administration].	Reumatisk > Lupus	Evidensbasert pasientinnspill > Bruk pasientinnsikt til å informere beslutninger	100 000	National	Regularly	119070039917
We have held multiple externally led patient-focused drug development (EL-PFDD [Externally Led Patient-Focused Drug Development]) meetings with the FDA [Food and Drug Administration].	Nyre > Nyresykdommer	Evidensbasert pasientinnspill > Bruk pasientinnsikt til å informere beslutninger	100 000	National	Regularly	119070696943
As a transgender-led healthcare organization, ETSI [Ending Transmission of Sexual Infections] also brings the perspective of historically marginalized communities into healthcare discussions. The clinic advocates for policies that protect medication affordability, expand HIV prevention services, and strengthen programs that reduce the cost of prescription drugs for safety-net providers. Through patient care, community engagement, and participation in public health programs, ETSI Health Clinic ensures that the voices and needs of vulnerable patients are represented in conversations about medication access and healthcare equity.	HIV > HIV og seksuell helse	Evidensbasert pasientinnspill > Bruk pasientinnsikt til å informere beslutninger	100	Regional	Regularly	119073874628
We provide data and real-world knowledge.	Lever > Leversykdommer: de fleste typer	Evidensbasert pasientinnspill > Gi Real-World Evidence (RWE) til regulatoriske myndigheter	100 000	National	Sometimes	119045306046
The Community Liver Alliance represents patient interests to regulators and policymakers responsible for advising on and determining drug pricing. We engage at the federal and state levels to ensure that the lived experiences of people affected by liver disease inform policy decisions related to drug access, affordability, and reimbursement. Our advocacy includes engagement with CMS [Centers for Medicare & Medicaid Services], participation in public comment opportunities (including those related to Medicare Drug Price Negotiation), collaboration with policymakers on PBM [Pharmacy Benefit Manager] reform, and education of regulatory stakeholders about the real-world impact of pricing decisions on patients with chronic and rare liver diseases. We elevate patient and caregiver voices to ensure pricing policies balance innovation with equitable and timely access to life-saving therapies	Lever > Leversykdommer: de fleste typer	Evidensbasert pasientinnspill > Gi Real-World Evidence (RWE) til regulatoriske myndigheter	100 000	National	Regularly	119059491202
ETSI [Ending Transmission of Sexual Infections] Health Clinic collaborates with pharmacy partners and public health systems to highlight the real-world impact that medication costs have on patients living with HIV and those at risk. By documenting patient barriers to medication access, the clinic helps inform healthcare partners and policymakers about the financial and systemic challenges patients face.	HIV > HIV og seksuell helse	Evidensbasert pasientinnspill > Gi Real-World Evidence (RWE) til regulatoriske myndigheter	100	Regional	Regularly	119073874628
We communicate to them that many HD [Huntington's Disease] families are low income, as often the one making the money is the one with HD.	Nevrodegenerativ > Huntingtons sykdom	Evidensbasert pasientinnspill > Bruk pasienthistorier og fortellinger fra levd erfaring	100 000	National	Sometimes	119017688949
The Community Liver Alliance engages at the federal and state levels to ensure that the lived experiences of people affected by liver disease inform policy decisions related to drug access, affordability, and reimbursement. We elevate patient and caregiver voices to ensure pricing policies balance innovation with equitable and timely access to life-saving therapies.	Lever > Leversykdommer: de fleste typer	Evidensbasert pasientinnspill > Bruk pasienthistorier og fortellinger fra levd erfaring	100 000	National	Regularly	119059491202
We might provide patient stories and testimonials when needed to ensure importance of continued access to a particular drug.	Nevrologisk > Migrene/andre hodepinelidelser	Evidensbasert pasientinnspill > Bruk pasienthistorier og fortellinger fra levd erfaring	100 000	National	Rarely	119060019780
Have written support letters from the "patient voice" as part of our advocacy efforts related to drug pricing.	Kreft > Kreft: hjerne	Evidensbasert pasientinnspill > Bruk pasienthistorier og fortellinger fra levd erfaring	1 000	National	Rarely	119061176158
Held an EL-PFDD [Externally-Led Patient-Focused Drug Development] meeting.	Nevrodegenerativ > Demens	Evidensbasert pasientinnspill > Gjennomfør undersøkelser/forskning for å generere data	Do not know	National	Sometimes	119052219350
Serve on the Alliance for Breast Cancer Policy [The Alliance for Breast Cancer Policy is a coalition of over 25 national patient advocacy organizations founded by Susan G. Komen. The network unites advocates, community members, and industry partners to drive federal policy changes that improve access to care, eliminate out-of-pocket costs, and improve outcomes]. We were just part of a manuscript written for the launch of the global Breast Cancer Care Quality Index: https://www.mdpi.com/1660-4601/23/2/207	Kreft > Kreft: bryst	Evidensbasert pasientinnspill > Gjennomfør undersøkelser/forskning for å generere data	100 000	International	Sometimes	119052475951
As a transgender-led healthcare organization, ETSI [Ending Transmission of Sexual Infections] also brings the perspective of historically marginalized communities into healthcare discussions. The clinic advocates for policies that protect medication affordability, expand HIV prevention services, and strengthen programs that reduce the cost of prescription drugs for safety-net providers. Through patient care, community engagement, and participation in public health programs, ETSI Health Clinic ensures that the voices and needs of vulnerable patients are represented in conversations about medication access and healthcare equity.	HIV > HIV og seksuell helse	Evidensbasert pasientinnspill > Oversett bevis og innsikt til politikkinnspill	100	Regional	Regularly	119073874628
... We work closely with the FDA and other drug agencies, like EMA [European Medicines Agency] and PDMA [Pharmaceuticals and Medical Devices Agency], to look at endpoints for drug trials, or how to improve drug trials to benefit sponsors and patients.	Nyre > Nyresykdommer	Diagnose og medisinlevering > Samarbeid om utforming av kliniske studier	100 000	National	Regularly	119070696943
Supporting legislation for multiple cancer early detection, including TV appearances and social media.	Kreft > Kreft: omsorgspersoner, familie, venner	Diagnose og medisinlevering > Støtte til screening og tidlig oppdagelse	1 000	Regional	Regularly	119036085844
Discussions about review and approvals of new screening technologies.	Kreft > Kreft: de fleste typer	Diagnose og medisinlevering > Støtte til screening og tidlig oppdagelse	100 000	National	Rarely	119045117950
USPTF [U.S. Preventive Services Task Force] input.	Kreft > Kreft: menn	Diagnose og medisinlevering > Støtte til screening og tidlig oppdagelse	100 000	National	Sometimes	119050776275
Sit on several panels.	Kreft > Kreft: bryst	Institusjonell styring > Sikre representasjon i statlige rådgivende organer	100	Regional	Regularly	119037236943
... The organization's flagship event - the annual Indo US Bridging RARE Summit brings together rare disease stakeholders, including scientists, patient advocates, government officials, biopharma executives, and policy experts who share a common goal: transforming the future of care for the 400 million people worldwide living with rare diseases.	Sjelden > Sjeldne sykdommer: de fleste typer	Institusjonell styring > Arbeide effektivt i nettverk med flere interessenter	100	International	Regularly	119038170136
Serve on the Alliance for Breast Cancer Policy [The Alliance for Breast Cancer Policy is a coalition of over 25 national patient advocacy organizations founded by Susan G. Komen. The network unites advocates, community members, and industry partners to drive federal policy changes that improve access to care, eliminate out-of-pocket costs, and improve outcomes]. We were just part of a manuscript written for the launch of the global Breast Cancer Care Quality Index: https://www.mdpi.com/1660-4601/23/2/207	Kreft > Kreft: bryst	Institusjonell styring > Arbeide effektivt i nettverk med flere interessenter	100 000	International	Sometimes	119052475951
We are not a lobbying organization, we are a 501 c-3 non-profit public charity. We sign on to letters with partner societies who are lobbying for better access to care. We host roundtables and advocacy awareness days with legislators where we raise awareness of current problems and offer solutions. One recent event was with the Governor of Virginia. We are planning a Spine Health Fair at the US Capitol in September.	Generell helse > Livsstil	Institusjonell styring > Arbeide effektivt i nettverk med flere interessenter	100 000	National	Sometimes	119074217249
We are typically advisors on ICER [Institute for Clinical and Economic Review] reviews, active in Lupus Caucus, convene MAPRx [Medicare Access for Patients Rx] for Medicare Part D, etc.[MAPRx is guided by the idea that every Medicare Part D beneficiary should have timely, affordable access to the medications they need to live a healthy life.]	Reumatisk > Lupus	Institusjonell styring > Arbeide effektivt i nettverk med flere interessenter	100 000	National	Regularly	119082751826

USA

Undersøkelsesinnsikt

Pasientgruppers stemmer

Pasientgruppers mål

Hvordan pasientgrupper samhandler med legemiddelregulatorer

Hvordan pasientgrupper får tilgang til legemidler

Få tilgang til alle funnene

Last ned eksempelrapporter